Sangamo Therapeutics (LTS:0R1D) Accounts Payable & Accrued Expense : $28.00 Mil (As of Mar. 2025)

View and export this data going back to 2014. Start your Free Trial

What is Sangamo Therapeutics Accounts Payable & Accrued Expense?

Sangamo Therapeutics's quarterly accounts payable & accrued expense declined from Sep. 2024 ($31.43 Mil) to Dec. 2024 ($19.37 Mil) but then increased from Dec. 2024 ($19.37 Mil) to Mar. 2025 ($28.00 Mil).

Sangamo Therapeutics's annual accounts payable & accrued expense declined from Dec. 2022 ($34.30 Mil) to Dec. 2023 ($34.22 Mil) and declined from Dec. 2023 ($34.22 Mil) to Dec. 2024 ($19.37 Mil).

Sangamo Therapeutics Accounts Payable & Accrued Expense Historical Data

The historical data trend for Sangamo Therapeutics's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sangamo Therapeutics Accounts Payable & Accrued Expense Chart

Sangamo Therapeutics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

22.48

17.31

34.30

34.22

19.37

Sangamo Therapeutics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															33.94	33.35	31.43	19.37	28.00

Sangamo Therapeutics Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Sangamo Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sangamo Therapeutics Inc (LTS:0R1D) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

SGMO:USA GBY:Germany

Address

501 Canal Boulevard, Richmond, CA, USA, 94804

Website

https://www.sangamo.com

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

Sangamo Therapeutics Headlines

No Headlines